Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Implements on market buyback

Clinuvel Pharmaceuticals
3:27pm
March 14, 2024
CUV have announced an on-market buy back of approximately 3% of the shares on issue. We had been calling out for capital management and viewed this was necessary given the significant cash stockpile whilst sitting on multi-year lows. While several issues continue to present an overhang for the stock in our view, we view this as a step in the right direction. We make no changes to our valuation at this stage however given the weakness following our last note, we move back to an Add recommendation.

Heading in the right direction

Australian Vintage
3:27pm
March 12, 2024
AVG saw a material improvement in profitability during the 1H24 with underlying EBITS up 59.9% on the pcp and 41% ahead of our forecast. FY24 guidance was reiterated with AVG expecting underlying EBITDAS to be directionally aligned with FY22 reflecting easing inflation and its cost out program. We recently upgraded our recommendation for AVG to an ADD on the view that it would deliver a material earnings recovery through FY24/25. Pleasingly, AVG’s 1H24 performance demonstrates that our investment thesis remains intact and if management continues to execute there is material upside potential on offer. A decision on the China wine tariffs and any corporate activity (e.g. recently confirmed in early talks with Accolade to merge), are key near-term share price catalysts.

Waiting for reasons to upgrade

Proteomics International Laboratories
3:27pm
March 11, 2024
Following a strong run over the last month, our target price range has now been reached. At the risk of going against clear share price momentum, we continue to wait for further detail on initial launch of the PromarkerD but also note our valuation only assumes commercial success in the US. Significant upside potential remains as the rollout progresses in the US and other jurisdictions, but also view the endometriosis and oesophageal cancer diagnostics will remain key and likely hold significant value with licensing opportunities. We maintain our target price of A$1.38, but our recommendation reduces to a Hold recommendation (from Speculative Buy).

Cost out the focus in a tougher revenue environment

Livehire
3:27pm
March 4, 2024
Given the heavy cost-out initiatives implemented in recent periods (operating costs -28% on pcp), LVH’s 1H24 result showed an improved NPAT loss vs the pcp (-A$4.6m vs -A$7.2m) despite a lower overall revenue performance (1H24 operating revenue of A$3.5m, -11% on pcp). We make several changes to our assumptions over the forecast period (details below). Our price target is reduced to A$0.11 (from A$0.15).

Funding raising provides a path forward

Control Bionics
3:27pm
March 4, 2024
CBL posted its 1H24 result which was an improvement on pcp. Management believe there are sufficient funds to drive the existing business in the core regions of US and Australia as well as move forward some new product development.

Focus on 2H asset sales completing

Cromwell Property Group
3:27pm
March 3, 2024
The key focus remains on reducing gearing and completing the sale of the Polish assets. Management noted that a letter of intent has been signed with binding commitments and if successful expects the sale to occur in 4Q24. Gearing sits at 44.7% and is estimated to fall to c34% post asset sales. No FY24 guidance has been provided, however CMW expects to pay a 0.75c distribution for the March quarter. The payout ratio has fallen vs historical levels (currently around 63%) so we will be looking for further clarity on the group’s longer term payout policy post asset sales and subsequent gearing reduction. We retain a Hold rating with a revised price target of $0.46. The key near term catalyst relates to the sale of the Polish assets.

Adding further scale to Industrial Services

Acrow
3:27pm
March 1, 2024
ACF has added to its Industrial Services capability by acquiring Benchmark Scaffolding in North QLD for $9m (pre earn-outs). The acquisition represents an EV/EBITDA multiple of 3.8x (pre earn-outs), which is largely in line with the MI Scaffold acquisition in November (4x). In our view, the deal is complementary to MI Scaffold and will increase ACF’s scale in Industrial Services in QLD as well as nationally. Management has increased FY24 EBITDA guidance by $1m to between $73-76m as a result of the acquisition. This implies no change to guidance for the existing ACF business. We estimate the deal to be 2% EPS accretive in FY25 (first full year of ownership). Our target price rises to $1.43 (from $1.40) following updates to earnings forecasts and we maintain our Add rating. Trading on 9.3x FY25F PE and 4.7% yield with strong business momentum and leverage to growing civil infrastructure activity over the long term, ACF remains one of our key picks in the small caps space.

Hearing the drum beat loud and clear

Audeara
3:27pm
March 1, 2024
AUA reported its 1H24 results. Key focus around OPEX as timing of restocking and initial EU sales orders remains irregular and hard to predict. Gross margin improvement due to customer mix but likely revert as larger distributors restock. Key news here was maiden sales order from the AUA technology division to drum equipment manufacturer Avedis Zildjian for A$2.1m. Lower margin versus own branded product, but provides scale and volume without the front-ended marketing and sales expense. Deals like this have potential to be a significant part of the business although hard to predict at this stage. Positive share price moves off the back of the technology order, but continue to see higher prices achievable as the business matures. Speculative Buy.

Bumper earnings, focus stays on growth

Karoon Energy
3:27pm
March 1, 2024
KAR delivered a strong December half result, with strong earnings and cash flow. Management flagged a continued focus on its growth. Remaining one of our top sector preferences, we maintain an Add rating.

Continued progress across the bulk of the portfolio

Frontier Digital Ventures
3:27pm
March 1, 2024
FDV’s FY23 NPAT of -A$8.59m (FY22 -A$10.2m) came in better than Morgans expectations (-A$10.5m), whilst statutory revenue (~A$68m, +15% on the pcp) was in-line with Morgans forecasts. While FDV Associate businesses continue to face economic headwinds, this result showed a continued improving earnings trajectory across FDV’s consolidated portfolio, in our view. We lift our FDV FY23F/FY24F EPS by >10% respectively mainly on improved group EBITDA margin assumptions. Our PT is largely unchanged at A$0.79 (previously A$0.77). We continue to be attracted to FDV’s long-term growth profile and the earnings potential of the assembled portfolio. ADD maintained. We lift our FDV FY23F/FY24F EPS by >10% respectively mainly on improved group EBITDA margin assumptions. Our PT is largely unchanged at A$0.79 (previously A$0.77).

News & Insights

In recent weeks, there has been much discussion about the inflationary effect of Trump tariffs. Our Chief Economist, Michael Knox shares his views.

In recent weeks, there has been much discussion about the inflationary effect of Trump tariffs. This is sparked by Donald J. Trump's proposal of a 10% revenue tariff. Interestingly, the idea of a 10% revenue tariff was first discussed during his first term. At that time, it was considered as a potential source of additional revenue to offset the Trump tax cuts enacted during his first term.

The challenge in passing finance bills in the U.S. lies in the legislative process. Finance bills can only be easily passed if they are reconciliation bills, meaning they have no effect on the budget balance. When a finance bill does not affect the budget balance, it requires only a simple majority in the U.S. Senate to pass. However, when a finance bill increases the budget deficit, it requires at least 60-votes in the Senate, making such bills much harder to pass.

During Trump's first term, the administration found that by reducing certain tax write offs or tax cuts for specific states, they could pass the overall tax bill without effecting the budget balance. This allowed significant tax cuts for individuals and a major corporate tax cut, reducing the U.S. corporate tax rate from 35% to 21%. Now, as Trump seeks to cut corporate taxes again—this time from 21% to 15%, matching the German corporate tax rate—he needs additional revenue to balance the bill. This is so he can pass it as a reconciliation bill, requiring only 51 Senate votes. This has led to renewed discussions about the 10% revenue tariff.

In contrast to the European Union, where a value-added tax (VAT) would be a straightforward solution, implementing a VAT in the U.S. is effectively impossible due to constitutional constraints. A VAT would require unanimous agreement from all states. This is impossible in practise. So, the idea of a 10% revenue tariff has resurfaced.

Critics, particularly within the Democratic Party, have argued that such a tariff would be highly inflationary. However, when questioned during confirmation hearings, Trump's Treasury secretary nominee, Scott Bessent, referencing optimal tariff theory, explained that a 10% revenue tariff would increase the U.S. dollar exchange rate by 4%. We note that this would result in a maximum inflationary effect of 6% only if 100% of domestic goods were imported. Given that only 13% of domestic goods are imported, the actual inflationary impact would be just 0.8% on the Consumer Price Index (CPI). This makes the tariff effectively inflation neutral.

This idea was discussed by a panel of distinguished economists at the American Economic Association Convention in January, including Jason Furman, Christy Romer, Ben Bernanke, and John Cochrane. Cochrane noted that historical instances of tariff increases, such as in the 1890s and 1930s, did not lead to inflation because monetary policy was tight. He argued that the inflationary impact of tariffs depends entirely on the Federal Reserve's monetary policy. If the Fed maintains a firm stance, there would be no inflationary effect.

Trump's current plan is to pass a comprehensive bill that includes the Reciprocal Trade Act, corporate tax cuts, and the 10% revenue tariff. Peter Navarro, in a CNBC interview on 21 January, estimated that the revenue tariff could generate between $US350and$US400 billion, offsetting the cost of the tax cuts and making the bill feasible as a reconciliation measure.

With the Republican Party holding enough Senate seats, the legislation could pass by the end of April. The inflationary impact of the tariff, estimated at 0.8%, can be easily managed through moderately tight monetary policy by the Federal Reserve.


Morgans clients receive access to detailed market analysis and insights, provided by our award-winning research team. Begin your journey with Morgans today to view the exclusive coverage.

      
Contact Us
      
Read more
Michael Knox discusses the challenges the Reserve Bank of Australia (RBA) faces in cutting rates. He explores a model of Australian short-term interest rates, and how its components interact.

Today, I want to discuss the challenges the Reserve Bank of Australia (RBA) faces in cutting rates. To do this, I’ll explore our model of Australian short-term interest rates, and how its components interact. A key focus will be the relationship between inflation and unemployment, and how this relationship makes it particularly difficult for the RBA to now lower rates.

Our model of the Australian cash rate is robust, explaining just under 90% of the monthly variation in the cash rate since the 1990s, when the cash rate was first introduced. The model’s components include core inflation (not headline inflation), unemployment, and inflation expectations.

Interestingly, statistical tests show that unemployment is even more important than inflation when it comes to predicting what the RBA will do with the cash rate. This is because of the strong, leading relationship between Australian unemployment and core inflation.

To illustrate this, I’ve used data from the past ten years up until December, which shows the relationship between unemployment and inflation in Australia. The data reveals a Phillips curve, where inflation tends to fall as unemployment rises. This relationship begins to work appears almost immediately, though there is a slight delay of about 3 to 4 months before its full effect is felt.

We look at the data from 2014 to the end of 2024. When unemployment is around 4%—which is where it has been for the past few months—we can predict that core inflation should be around 3.7%. Currently, core inflation is 3.5%, which aligns closely with what we would expect given the unemployment rate. This suggests that the current level of inflation is consistent with current unemployment levels.

Unemployment vs Inflation

2014 to 2024

However, the RBA’s target inflation rate is between 2 and 3%, with a specific target of 2.5%. To achieve this target, unemployment would need to rise from its current level of 4% to around 4.6% or 4.7%. Historical data, such as from 2021, shows that with an unemployment rate of around 4.6%, inflation can be brought down to 2.5%. Therefore, to reduce inflation to the RBA’s target, the unemployment rate would need to increase slightly—though not drastically. If unemployment were allowed to rise to around 4.6%, it would create enough excess capacity in the economy to put downward pressure on inflation, which would take about 3 to 4 months to materialise.

If the RBA were able to allow this rise in unemployment, inflation would decrease to around 2.5%, and the RBA could cut rates. Current rates are at 4.35%, and under this scenario, we could expect them to drop to the low 3.0% range perhaps even lower. This would represent a fall of around 100 basis points from current levels.

Unfortunately, the situation is complicated by fiscal policy. The current Treasurer, Jim Chalmers, has been expanding employment in sectors like the National Disability Insurance Scheme (NDIS) and other areas of the public service. This fiscal stimulus is preventing unemployment from rising to the level needed for inflation to fall. As a result, unemployment remains stuck at around 4%, and inflation remains too high for the RBA to cut rates.

In terms of job vacancies and other labour market indicators, we would have expected unemployment to rise higher by now. However, Treasurer Chalmers is committed to keeping unemployment low ahead of the election, which is why we find ourselves in this position.

The government’s fiscal policy, aimed at maintaining a low unemployment rate, is preventing the necessary adjustment to bring inflation down.

If I input the current levels of inflation, unemployment, and inflation expectations into our model, the estimated cash rate should be 4.45%. This is 10 basis points higher than the current cash rate of 4.35%.

The Australian Government seems intent on maintaining the unemployment rate at 4% ahead of the election. If it does so, Inflation will remain too high for the RBA to cut rates.

Read more
The federal government has recommended a number of changes to the cost of residential aged care, which will commence from the beginning of 2025. Read more about the main measures to be introduced.

Following the release of the Aged Care Taskforce report earlier this year, the federal government has recommended a number of changes to the cost of residential aged care, some will commence from the beginning of 2025 and the remainder expected to commence from 1 July 2025.

Over the next 40 years, the number of people over 65 is expected to at least double and the number of people over 85 expected to triple. A significant amount needs to be invested in the Aged Care sector, by both government and private sector, to be able to manage the growing numbers of older people needing care and support in their later years.

From 1 January 2025:

  • Increasing the refundable accommodation deposit (RAD) maximum amount without approval from $550,000 to $750,000. This amount will be indexed annually.

From 1 July 2025:

  • Introduce a RAD retention amount of 2% pa to a maximum of 10% over 5 years.
  • Removing the annual fee caps and increasing the lifetime fee caps to $130,000 or 4 years, whichever occurs first.
  • Introducing a means-tested hotelling supplement of $12.55 per day which is to be indexed.
  • Removing the means tested fee and replacing it with a means tested non-clinical care contribution (NCCC). The daily maximum is $101.16 which is to be indexed.

From 2029/30:

  • The government is looking to commence a phase out RAD altogether by 2035. A commission will be established to independently review the sector in readiness.

Grandfathering arrangements will protect anyone who enters care prior to 1 July 2025 under the “no worse off” principle to ensure they do not pay more for their care.

Comparison of current and new aged care costs

Current aged care fees

The Basic Daily fee continues to be paid by all residents without change.

The Hotelling Supplement is paid by residents as a contribution towards their living costs. It is a means tested payment calculated at 7.8% of assets greater than $238k or 50% of income over $95,400 (or a combination of both). The Hotelling Supplement is capped at $12.55 per day (indexed).

The Non-Clinical Care Contribution (NCCC) replaces the current means tested fee. The NCCC is a contribution towards the cost of non-clinical care services which will be capped at $101.16 per day (indexed). It is a means tested fee calculated at 7.8% of assets over $501,981 or 50% of income over $131,279 (or a combination of both).

The lifetime cap for the NCCC is increasing to $130,000 or 4 years, whichever occurs first, indexed twice per year. There is no longer an annual cap.

Any contributions made under the home support program prior to entering residential aged care will count towards the NCCC cap.

Who will likely pay more from 1 July 2025?

It is expected that at least 50% of people entering care will pay more for their care each year.

The below chart illustrates the expected changes for regular care costs (excluding accommodation costs and retention amounts) for individuals based on specific asset levels:

Should you enter residential aged care before 1 July 2025?

It depends. For some people, if they have an ACAT assessment and are eligible to enter residential aged care, then it would be best to seek advice from your Morgans Adviser on both the current and future cost as well as cash flow and cost funding advice.


Contact your Morgans adviser today to schedule an aged care advice appointment. Our expert team will be able to simplify the aged care system, guide you through Government subsidies, analyse payment options, create 5-year cash flow projections, and model the benefits of home concessions and future asset values for your beneficiaries.

      
Contact Us
      
Read more